ESR1 and cancer: Abundant immune cell infiltration was experienced around “immune-hot” hormone receptor-negative breast cancers with a predominance of B cells, Th1 T cells, and cytotoxic T lymphocytes (CTLs), while ER-positive cancers proved to be immune-cold [123].